A medical graduate has a Ph.D. in Clinical Neuroscience (ICMR MD-PhD Program) at NIMHANS, Bangalore, India, PhD work was on Structural Neuroimaging: MRI-Diffusion Tensor Imaging in Alzheimer's dementia. Trained in Health Technology Assessment with an MSc (Health Technology Assessment) degree from Mahidol University, Bangkok, Thailand. Currently working as Scientist in ICMR-National Institute of Epidemiology.
Economics and Econometrics, Neuroscience, Public Health, Environmental and Occupational Health, Multidisciplinary
121
Scopus Publications
2461
Scholar Citations
28
Scholar h-index
68
Scholar i10-index
Scopus Publications
Efficacy and safety of stem cell therapy in patients with Diabetes Mellitus – a systematic review and meta-analysis Manikandan S, Roopa Hariprasad, Bhavani Shankara Bagepally Systematic Reviews, 2026 To support the development of a national guideline on stem cell therapy, the Department of Health Research, India, commissioned this systematic review to evaluate the efficacy and safety of various stem cell types in patients with type 1 and type 2 diabetes mellitus (DM), focusing on patient-important outcomes. Following PRISMA guidelines, a literature search was conducted in PubMed, Embase, Web of Science, and Cochrane databases from inception to August 30, 2024. Critical outcomes for type 1 DM included insulin-free periods, hypoglycemic episodes, quality of life, and serious adverse events. For type 2 DM, outcomes included HbA1c, insulin requirements at 6, 12, and 24 months, and serious adverse events. Meta-analyses used random- or fixed-effects models based on heterogeneity (Chi-square test and I2). Risk of bias was assessed using the Cochrane Risk of Bias Tool 2.0, and evidence certainty was evaluated with GRADE. The search identified 11,026 articles, of which 20 randomized controlled trials (RCTs) were included, encompassing 427 and 351 patients in the intervention and control groups, respectively, with follow-ups ranging from 3 to 96 months. Predominantly studied therapies included mesenchymal and bone marrow mononuclear stem cells. In type 1 DM, stem cell therapy showed no significant improvement in quality of life [MD: 3.15% (95% CI: -0.80 to 7.10); 2 trials, n = 63 participants; I2 = 0%; GRADE: very low certainty] or reduction in hypoglycemic episodes [RR: 0.90 (95% CI: 0.56 to 1.45); 3 trials, 68 participants; I2 – 0%; GRADE: very low. In type 2 DM, stem cell therapy significantly reduced insulin requirements at 6, 12, and 24 months, with MDs in IU/day of -14.42 (95% CI: -24.25 to -4.59); 6 trials, n = 167 participants; I2 = 91.64%; GRADE: low certainty; -17.79 (95% CI: -26.39 to -9.18); 6 trials, n = 212 participants; I2 = 70.96%; GRADE: low certainty; and -35.73 (95% CI: -40.82 to -30.64); 1 trial, n = 61 participants; I2 = NA; GRADE: very low certainty, respectively, with a low certainty of evidence. Stem cell therapy did not achieve an insulin-free state or improved quality of life in type 1 DM patients. However, it reduced insulin requirements by 14–36 units over 6–24 months in type 2 DM patients, without significant glycemic control. Larger, high-quality RCTs with extended follow-ups are essential to determine the therapeutic potential of stem cell therapy in diabetes mellitus. PROSPERO ID: CRD42023451602.
Out of pocket expenditure incurred by couples seeking infertility services at tertiary level facilities in India Asim Kumar Padhan, Prerana Patil, Akshita Vikani, Deepshikha Sharma, Oshima Sachin, Biju Somen, Bhavani Shankara Bagepally, Renu Tanwar, Vanita Suri, Radha V., Anitha M., Ramesh P., Deepti Shrivastava, Sukhpreet Patel, Shankar Prinja, Beena Joshi Indian Journal of Medical Research, 2026 Background and objectives Diagnosis and treatment of infertility, mostly sought at tertiary facilities, contribute to substantial out-of-pocket expenditure (OOPE). This study estimated OOPE among couples seeking care for endometriosis, male infertility, polycystic ovary syndrome (PCOS), tubal factor, and uterine factor, including costs of diagnosis, management, and intrauterine insemination (IUI). Methods A cross-sectional study was conducted across five tertiary healthcare facilities (three public, two private) selected through convenience sampling to represent different regions. Based on mean (SD) OOPE INR (₹)144,393 (₹130,943), effect size 0.16, α=0.05, and 80% power, the sample was equally distributed across sites and IVF/non-IVF groups, with ∼100 participants per site. Couples were interviewed between April 2022–March 2023. Catastrophic health expenditure was defined as infertility spending exceeding 40% of annual household non-food expenditure. OOPE over the preceding year covered direct medical, non-medical, and indirect costs. Results Annual median OOPE was ₹11,317 (US $136.5) (IQR: ₹4,801–₹19,513) US $, higher in private facilities ₹14,217 ($171.4) (IQR: ₹8,030–₹21,848) than public facilities ₹8,355 ($100.7) (IQR: ₹3,785–₹17,386). Direct medical costs were the major contributor: median ₹5,802 ($69.9) (IQR: ₹2,186–₹11,847) Highest OOPE was for endometriosis ₹15,084 ($181.9) (IQR: ₹8,114–₹20,758), followed by uterine factor and male infertility ₹13,211 ($159.3) (IQR: ₹6,654–₹21,521). OOPE increased with absence of insurance (₹6,919; $83.4), comorbidities (₹2,593; $31.3), IUI (₹2,668; $32.1), and PCOS (₹2,004; $24.1). Catastrophic Health Expenditure was associated with comorbidities (OR=1.61), IUI (OR=1.88), and lower per capita income <₹59,400 ($715.7) (OR=3.44). Overall, 59.4% experienced CHE. Interpretation and conclusions Infertility care imposes substantial out of pocket expenditure in India. Strengthened insurance coverage and public sector investment are critical for equitable access.
Efficacy of Metabolic and Bariatric Surgery Compared with GLP-1 Receptor Agonist Treatment in Preventing Mortality and Major Adverse Cardiac Events Among Individuals with Obesity and Type 2 Diabetes: A Systematic Review and Meta-analysis Joshua Chadwick, Chandru Sivamani, Suchitra Lakshmi, Vishali Baskaran, Swathi N.L., Lavanya Ayyasamy, Ganeshkumar Parasuraman, Bhavani Shankara Bagepally Obesity Surgery, 2026 Obesity and type 2 diabetes mellitus (T2DM) significantly increase cardiovascular morbidity and mortality worldwide. Metabolic and bariatric surgery (MBS) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective interventions for T2DM and obesity, but comparative evidence on their long-term impact on major adverse cardiovascular events (MACE) and all-cause mortality is lacking. This systematic review and meta-analysis evaluated the efficacy of MBS versus GLP-1 RAs therapy in reducing these outcomes. The review was registered in PROSPERO beforehand and carried out following the PRISMA framework. A comprehensive literature search identified randomized controlled trials (RCTs) and observational studies comparing MBS with GLP-1 RAs regimens in adults with obesity and T2DM. The primary outcomes were all-cause mortality and MACE. We used the Cochrane Risk of Bias 2.0 (ROB 2) tool and Newcastle-Ottawa Scale (NOS) to assess the quality of the study. Meta-analytic techniques were used to synthesize effect estimates. Pooled analysis of eligible studies suggested that MBS offered greater reductions in both MACE and all-cause mortality than GLP-1 RAs therapy. The relative risk reduction for MACE was approximately 52% in favor of MBS. Despite notable heterogeneity, sensitivity analyses confirmed result robustness. The overall certainty of evidence was moderate, reflecting variations in populations, interventions, and study designs. MBS offers significantly greater cardiovascular protection than GLP-1 RAs therapy in individual with obesity and T2DM, reducing MACE and all-cause mortality. GLP-1 RAs remains an important option, particularly for patients contraindicated for surgery or preferring pharmacotherapy. Further long-term comparative and cost effectiveness studies are needed to inform the clinical decisions.
Efficacy and safety of stem cell therapy vs. standard of care in patients diagnosed with acute respiratory distress syndrome: an updated systematic review and meta-analysis of randomized controlled trials Jerin Jose Cherian, Saibal Das, Bhavani Shankara Bagepally, Madhavi Eerike, Sayan Nath, Alka Khadwal Frontiers in Medicine, 2026 Objectives This systematic review and meta-analysis aimed to evaluate the efficacy and safety of stem cell therapies as compared to the standard of care (SOC) in patients with acute respiratory distress syndrome (ARDS). Methods Search of PubMed, Embase, Cochrane CENTRAL, and Web of Science databases for randomized controlled trials was performed. The protocol was registered in PROSPERO (ID: CRD42023467612). The primary outcomes were all-cause mortality on day 28 and serious adverse events. Risk ratios (RR) and mean differences were pooled using Stata software version 17.0. Quality of the evidence was assessed by GRADE approach. Results Out of 5,537 articles screened, 17 were included. Treatment with stem cells led to no significant difference in the risk of 28-day mortality [RR, 0.809 (95% CI: 0.651–1.005), p = 0.06; I 2 = 0%] or the risk of serious adverse events [RR, 0.94 (95% CI: 0.80–1.12), p = 0.36; I 2 = 8.58%] as compared to treatment with SOC. Additionally, no significant differences were observed in the duration of hospitalization, the number of ventilator-free days till day 28, 60-day all-cause mortality, intensive care unit (ICU)-free days till day 28, change in quality-of-life (QoL) score, and the duration of ICU stay, PaO 2 /FiO 2 ratio, change in SOFA score, and change in serum interleukin 6 and 8 levels. The GRADE of evidence was low or very low for the critical outcomes. Conclusion There was no significant improvement in critical outcomes following stem cell therapy as compared to the SOC in ARDS. The certainty of evidence was low to very low, indicating limited confidence in the findings. Systematic Trial registration PROSPERO (ID: CRD42023467612)
Coverage and determinants of Mass Drug Administration against lymphatic filariasis in Southeast Asian regional countries during the end-game strategy: A systematic review and meta-analysis Indranil Saha, Joydeep Majumder, Bhavani Shankara Bagepally, Deepanjan Ray, Saibal Das, Manoj Kalita, M Devaraja, Anoop Velayudhan, Devi Das, Bobby Paul, Sanjit Dey Journal of Vector Borne Diseases, 2026 Background & objectives: Mass Drug Administration (MDA) is one of the important pillars of eliminating lymphatic filariasis. The present study aimed to determine the pooled coverage and compliance of MDA and its determinants in the Southeast Asian regional countries. Methods: This proposal was registered in PROSPERO. The study focused on four databases (PubMed, Scopus, Embase, and Cochrane Central) and articles published between January 2019 and March 2025. The setting was taken from studies performed across the Southeast Asian Region. Stata Version 17 was used for meta-analysis of the selected studies. The overall and subgroup-wise analysis was computed using the DerSimonian-Laird method for the random-effects model in Forest plots. A funnel plot was done to find out the publication bias. Results: Altogether, 34 articles were analysed. Of the 34 articles, 28 (82.3%) and 4 (11.8%) articles were published in India and Indonesia, respectively. The pooled coverage and compliance of MDA were found to be 80.16% (95% CI: 74.68-85.64%) and 67.25% (95% CI: 60.17-74.33%), respectively. Subgroup-wise, both coverage and compliance decreased in studies conducted in 2020 or afterwards. Side effects of the drugs, non-diseased status, suffering from some other diseases, too many drugs, bad taste of the drugs were some of the common barriers to successful MDA implementation. Interpretation & conclusion: Thus, time has come to develop strategies to improve MDA coverage and compliance at the community level. The strategy would be bilateral, involving both providers and beneficiaries, who need to be engaged in the proper implementation of MDA administration at the grassroot level.
Pulmonary function among flour mill workers: a systematic review and meta-analysis Kuldip Upadhyay, Bhavani Shankara Bagepally, Rakesh Balachandar, Ankit Sheth, Ankit Viramgami BMC Public Health, 2025 Flour dust, with an inherent allergic nature, increases vulnerability to various respiratory ailments. We systemically reviewed and compared literature-reported pulmonary function parameters to quantify pulmonary dysfunction among individuals with high flour dust exposure (among flour mill workers) and relatively un-exposed groups. Studies that compared pulmonary function parameters for flour dust exposed and unexposed control groups were systemically searched in PubMed, Scopus and Embase from inception to June 2024. The Newcastle Ottawa scale was used to assess the risk of bias among included studies. With the random effect model, we pooled (along with 95% CI) the mean difference for forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), the ratio of FEV1 & FVC, mid-expiratory flow (FEF25-75%), peak expiratory flow rate (PEFR) and other pulmonary function parameters. Cochran-Q test and I2 statistics were applied to determine heterogeneity. This quantitative synthesis included twenty-two studies involving 2,482 flour dust exposed and 1,925 control participants. The pooled mean difference for FEV1, FVC, FEV1/FVC, PEFR and FEF25 − 75% were − 0.43 L (-0.57, -0.29; I2 = 88.7), -0.49 L (-0.64, -0.33; I2 = 89.3), -3.5% (-6.49, -0.5; I2 = 89.7), -1.36 L/s (-1.70, -1.03; I2 = 90.4) and − 0.34 L/s (-0.63, -0.06; I2 = 77.3). The pooled odds ratio for obstructive [12.9 (3.41, 49.2); I2 = 82.4)] and restrictive changes [5.11 (0.55, 47.4); I2 = 81.6] were significantly higher among the exposed than controls. As per the bias assessment majority of studies rated with moderate to severe risk of bias. Study observed pulmonary function deficits associated with exposure to flour dust. However, considering the quality of primary studies and higher heterogeneity, high-quality larger studies with longitudinal design are required to affirm the effects of flour dust on lung function.
Prevalence and associated factors of undernutrition among adolescents in India: a systematic review Jayashree Parida, Bhavani Shankara Bagepally, Prasanna Kumar Patra, Sanghamitra Pati, Harpreet Kaur, Subhendu Kumar Acharya BMC Public Health, 2025 BACKGROUND: Undernutrition is a major public health challenge among Indian adolescents in India where 253 million of them are in the age group of 10-19 years. In spite of several intensive efforts through various program interventions and care, research studies find a less encouraging improvement in nutritional scenarios. The present systematic review aimed to determine the pooled prevalence and associated factors of undernutrition (stunting and underweight) among Indian adolescents. METHODS: We searched e-databases of MEDLINE/PubMed, EMBASE, Google Scholar, and Cochrane library for the period between the years 2000 and 2021. The peer-reviewed and empirical studies analyzing the prevalence of undernutrition among Indian adolescents and its associated factors were eligible for inclusion. The quality of the study reports included in the review was evaluated using the Newcastle-Ottawa Scale. The random-effect model with the Dersimonian and Laird method, at 95% confidence intervals, was used for estimating the overall effect. Subgroup analysis was conducted to investigate the possible sources of heterogeneity. Publication bias was assessed through visual examination of funnel plots and objectively by Egger's regression test. RESULTS: A total of forty eligible studies with a pooled sample size of 67,865 adolescents were included to determine the prevalence of undernutrition among adolescents in India. The pooled prevalence of stunting and underweight in India was 41.1% (95% CI: 35.9, 46.0) and 32.6% (95% CI: 26.8, 37.1) respectively. It was also found that the rate of stunting prevalence was high among late adolescents and underweight was high among early adolescents. Age, gender, income, family size, caste, parental education, and occupation were the significant associated factors of the prevalence of stunting and underweight among adolescents in India. CONCLUSION: The prevalence of stunting and underweight among adolescents is still a high concern in India. The results of this review posit the need of an integrated effort to reduce undernutrition in India and identify research priorities in this field.
Cost of TB care and equity in distribution of catastrophic TB care costs across income quintiles in India Kathiresan Jeyashree, Jeromie W. V. Thangaraj, Devika Shanmugasundaram, Sri Lakshmi Priya Giridharan, Sumit Pandey, Prema Shanmugasundaram, Sabarinathan Ramasamy, Venkateshprabhu Janagaraj, Sivavallinathan Arunachalam, Rahul Sharma, Vaibhav Shah, Bhavani Shankara Bagepally, Joshua Chadwick, Hemant Deepak Shewade, Aniket Chowdhury, Swati Iyer, Raghuram Rao, Sanjay K. Mattoo, Manoj V. Murhekar Global Health Research and Policy, 2024
Apolipoprotein e polymorphism and dementia: A hospital-based study from southern India Srikala Bharath, Meera Purushottam, Odity Mukherjee, Bhavani Shankara Bagepally, Om Prakash, Lakshminarayanan Kota, Srinivas Brahmadevarahalli Krishnappa, Palanimuthu Thangaraju Sivakumar, Sanjeev Jain, Mathew Varghese Dementia and Geriatric Cognitive Disorders, 2011
Burden of Mental Health Outcomes and Job Burnout Among Coal Mine Workers and Synthesis of Intervention Measures: A Systematic Review & Meta-Analysis I Saha, J Majumder, BS Bagepally, S Das, M Kalita, D Munikrishnappa, ... Psychiatry International 7 (3), 111 , 2026 2026
Health economic evaluation studies in India’s traditional system of medicine (Ayush): A scoping review S Muthappan, BS Bagepally, M Malaisamy, R Sheeja, A Kumar, ... Journal of Family Medicine and Primary Care 15 (4), 1515-1523 , 2026 2026
Efficacy of Metabolic and Bariatric Surgery Compared with GLP-1 Receptor Agonist Treatment in Preventing Mortality and Major Adverse Cardiac Events Among Individuals with … J Chadwick, C Sivamani, S Lakshmi, V Baskaran, S NL, L Ayyasamy, ... Obesity Surgery, 1-12 , 2026 2026
Fluoride varnish for preventing dental caries among children: a systematic review and meta-analysis of cost-effectiveness studies RS Kumar, A Gupta, S Sharda, BS Bagepally, N Monga, A Goyal Journal of Dentistry, 106562 , 2026 2026
Efficacy and safety of stem cell therapy in patients with Diabetes Mellitus–a systematic review and meta-analysis R Hariprasad, BS Bagepally Systematic Reviews , 2026 2026
Workplace exposure to aflatoxins & its health effects: A systematic review G Mathew, LM Thayil, P Shenoy, M Sasidharan, P Kumar, P Selvam, ... The Indian Journal of Medical Research 162 (6), 809 , 2026 2026
Coverage and determinants of Mass Drug Administration against lymphatic filariasis in Southeast Asian regional countries during the end-game strategy: A systematic review and … I Saha, J Majumder, BS Bagepally, D Ray, S Das, M Kalita, M Devaraja, ... Journal of Vector Borne Diseases 63 (1), 27-35 , 2026 2026 Citations: 1
Development of a competency framework for health technology assessment in India S Dixon, K Tyagi, M Singh, SS Kar, BS Bagepally, S Prinja, A Booth, ... BMJ evidence-based medicine 30 (Suppl 2), s43-s47 , 2025 2025 Citations: 2
Prevalence of depressive symptoms, anxiety, sleep & substance use disorders among older adults in LMICs: A systematic review & meta-analysis D Das, M Khasnobis, S Dutta, S Hoda, A Pal, N Dahiya, A Saha, ... The Indian Journal of Medical Research 162 (3), 293 , 2025 2025
Burden of mental health disorders and synthesis of mental health intervention measures among coal mine workers across the globe: A Systematic Review & Meta-Analysis I Saha, J Majumder, BS Bagepally, S Das, M Kalita, U Mondal, D Das, ... 2025
Health-seeking behavior for infertility: A systematic review and meta–analysis R Elumalai, S Jaisankar, BS Bagepally, R Vembu, T Bhatnagar European Journal of Obstetrics & Gynecology and Reproductive Biology, 114777 , 2025 2025 Citations: 3
Association between occupational cadmium exposure and markers of kidney injury: A systematic review and Meta-Analysis R Kalahasthi, R Nagaraju, R Balachandar, K Upadhyay, BS Bagepally Chemical Research in Toxicology 38 (10), 1638-1651 , 2025 2025 Citations: 6
Implementation of an Interdepartmental Collaborative Medication Review to Reduce Potentially Inappropriate Medication Use in Hospitalized Older Adults: Protocol for a Mixed … A Kumar, RK Konduru, S Rajaram, M Mani, A Natarajan, JJ Cherian, ... JMIR Research Protocols 14 (1), e69626 , 2025 2025 Citations: 1
Cost-utility analysis of Add-on SGLT2 Inhibitors for Heart failure with reduced ejection fraction in India A Sasidharan, G Suchitralakshmi, K Rajsekar, BS Bagepally Health Policy and Technology, 101077 , 2025 2025
Modelling the relationship between extreme temperature metrics and cardiovascular disease burden in India: Insights from a multi-state study on climate change challenges for … S Soundararajan, BS Bagepally, J Dhingra, MP Dinesh, K Nimithamohan, ... Clinical Epidemiology and Global Health 34, 102084 , 2025 2025
Estimation of the pooled mean blood lead levels of Indian children: Evidence from systematic review and meta-analysis K Upadhyay, R Balachandar, BS Bagepally, K Ravibabu, V Dhananjayan, ... Toxicology Reports 14, 101975 , 2025 2025 Citations: 3
Study on the association between night shift work and reproductive functions among male workers: a systematic review and meta-analysis A Viramgami, R Balachandar, BS Bagepally, A Sheth Endocrine 88 (2), 410-419 , 2025 2025 Citations: 8
Cost effectiveness of obstructive sleep apnea therapies: a systematic review and meta-analysis of cost utility studies S Sajith Kumar, G Suchitra Lakshmi, A Sohail, KV Jagadeesh, ... Expert Review of Pharmacoeconomics & Outcomes Research 25 (4), 507-515 , 2025 2025
State-wise economic burden of road traffic injuries in India BS Bagepally, A Sasidharan, KV Jagadeesh, M Ponnaiah Injury Prevention , 2025 2025
Efficacy and safety of platelet-rich plasma as an adjunct therapy to split thickness skin graft in burn patients with granulating raw wounds: a prospective, randomized, double … S Behera, B Mishra, JJ Cherian, G Kumar, S Mahapatra, A Mukherjee, ... Trials 26 (1), 83 , 2025 2025 Citations: 5
MOST CITED SCHOLAR PUBLICATIONS
The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019 G Singh, M Sharma, GA Kumar, NG Rao, K Prasad, P Mathur, JD Pandian, ... The Lancet Global Health 9 (8), e1129-e1144 , 2021 2021 Citations: 147
Decrease in cerebral and cerebellar gray matter in essential tremor: A voxel‐based morphometric analysis under 3T MRI BS Bagepally, MD Bhatt, V Chandran, J Saini, RD Bharath, MK Vasudev, ... Journal of Neuroimaging 22 (3), 275-278 , 2012 2012 Citations: 131
Global prevalence of asymptomatic dengue infections-a systematic review and meta-analysis PR Asish, S Dasgupta, G Rachel, BS Bagepally, CPG Kumar International Journal of Infectious Diseases 134, 292-298 , 2023 2023 Citations: 105
Meta-analysis of economic evaluation studies: data harmonisation and methodological issues BS Bagepally, U Chaikledkaew, N Chaiyakunapruk, J Attia, ... BMC health services research 22 (1), 202 , 2022 2022 Citations: 70
Diffusion tensor imaging: tract based spatial statistics study in essential tremor J Saini, BS Bagepally, MD Bhatt, V Chandran, RD Bharath, C Prasad, ... Parkinsonism & related disorders 18 (5), 477-482 , 2012 2012 Citations: 70
Blood lead levels and male reproductive hormones: a systematic review and meta-analysis R Balachander, BS Bagepally, R Kalahasthi, M Haridoss Toxicology , 2020 2020 Citations: 65
Neuropsychological and imaging profile of patients with Parkinson's disease and freezing of gait J Menka, J Ketan, B Bhvani, shankara, S Jitender, K J, Keshav, Y Ravi, ... Parkinsonism & Related Disorders 21 (10), 1184–1190 , 2015 2015 Citations: 61
Health‐related quality of life in rheumatoid arthritis: Systematic review and meta‐analysis of EuroQoL (EQ‐5D) utility scores from Asia M Haridoss, BS Bagepally, M Natarajan International Journal of Rheumatic Diseases 24 (3), 314-326 , 2021 2021 Citations: 57
Incremental net monetary benefit of bariatric surgery: systematic review and meta-analysis of cost-effectiveness evidences P Noparatayaporn, M Thavorncharoensap, U Chaikledkaew, ... Obesity surgery 31 (7), 3279-3290 , 2021 2021 Citations: 54
Subcortical structural abnormalities in juvenile myoclonic epilepsy (JME): MR volumetry and vertex based analysis J Saini, S Sinha, BS Bagepally, CT Ramchandraiah, K Thennarasu, ... Seizure 22 (3), 230-235 , 2013 2013 Citations: 52
Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-analysis BS Bagepally, YK Gurav, T Anothaisintawee, S Youngkong, ... Value in Health, DOI: https://doi.org/10.1016/j.jval.2019 , 2019 2019 Citations: 50
Cost-effectiveness of surgical mask, N-95 respirator, hand-hygiene and surgical mask with hand hygiene in the prevention of COVID-19: Cost effectiveness analysis from Indian … BS Bagepally, M Haridoss, M Natarajan, K Jeyashree, M Ponnaiah Clinical Epidemiology and Global Health 10, 100702 , 2021 2021 Citations: 49
Association between lead exposure and DNA damage (genotoxicity): systematic review and meta-analysis R Nagaraju, R Kalahasthi, R Balachandar, BS Bagepally Archives of Toxicology 96 (11), 2899-2911 , 2022 2022 Citations: 47
Diffusion tensor imaging (DTI) and its clinical correlates in drug naive Wilson’s disease R Jadav, J Saini, S Sinha, B Bagepally, S Rao, AB Taly Metabolic Brain Disease 28 (3), 455-462 , 2013 2013 Citations: 47
Association between chronotype and cardio-vascular disease risk factors: A systematic review and meta-analysis D Bhar, BS Bagepally, B Rakesh Clinical Epidemiology and Global Health 16, 101108 , 2022 2022 Citations: 43
Systematic review and meta-analysis of gallstone disease treatment outcomes in early cholecystectomy versus conservative management/delayed cholecystectomy BS Bagepally, M Haridoss, A Sasidharan, KV Jagadeesh, NK Oswal BMJ Open Gastroenterology 8 (1) , 2021 2021 Citations: 42
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis N Jahan, A Brahma, MS Kumar, BS Bagepally, M Ponnaiah, T Bhatnagar, ... International Journal of Infectious Diseases 116, 59-67 , 2022 2022 Citations: 41
Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies BS Bagepally, U Chaikledkaew, YK Gurav, T Anothaisintawee, ... BMJ Open Diabetes Research & Care 8 (1), e001020 , 2020 2020 Citations: 41
Subcortical structures in progressive supranuclear palsy: vertex-based analysis. J Saini, B Bagepally, M Sandhya, R Yadav, k Thennarasu, P Pal European Journal of Neurology. 20 (3), 493-501 , 2013 2013 Citations: 41
In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS J Saini, BS Bagepally, M Sandhya, SA Pasha, R Yadav, PK Pal Neuroradiology 54 (7), 771-780 , 2012 2012 Citations: 40
